WD-910
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WD-910, covering 2025-04-02 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants [Phase 1]